We are live on
!
Find out more
VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
39 hedge funds and large institutions have $182M invested in Verona Pharma in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.15% less ownership
Funds ownership: 7.69% → 7.55% (-0.15%)
7% less funds holding
Funds holding: 42 → 39 (-3)
27% less capital invested
Capital invested by funds: $248M → $182M (-$66.3M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
39
Holders Change
-3
Holders Change %
-7.14%
% of All Funds
0.62%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
4
Increased
9
Reduced
4
Closed
7
Calls
$79K
Puts
–
Net Calls
+$79K
Net Calls Change
+$476K
Top Buyers
| 1 |
Citigroup
New York
|
+$2.15M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
+$1.04M |
| 3 |
PA
Perceptive Advisors
New York
|
+$1.03M |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$76.5K |
| 5 |
Millennium Management
New York
|
+$63K |
